STX · Investment summary · as of 29 July 2026
Priced slightly ahead of what the business has demonstrated
Business type: cyclical or commodity-sensitive
The operating path required by today's price is not achievable on the evidence.
At $764.20, STX requires a 35% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 34%.
The value rests on an exit multiple of 12.6x and a terminal operating margin of 35%. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: Named cause: a hyperscaler-funded second source, or CY2028 LTA renewal at flat-to-down $/TB.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | Exogenous-cycle driven: gross margin range 10.2% (FQ1'24) to 52.3% (FQ4'26); operating margin range -16.9% to +43.0% over 81 quarters of normalized statements. |
| What do we forecast? | Revenue growth of 34% demonstrated; a terminal operating margin of 35%; an exit multiple of 12.6x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is -0.7 percentage points. |
| What is it worth? | Twelve-month target $860.00, +13% from the struck price. Scenario-weighted expected return net of costs +12.5%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
| Date or window | Event | Thesis confirmed if | Thesis weakened or refuted if |
|---|---|---|---|
| 27 October 2026 | Next results (date estimated, not issuer-confirmed) | Revenue and margin in line with, or above, the house path | A miss that moves the full-year path below the guided floor |
| ber-2026 | Mozaic 4 qualification at the remaining CSPs slips beyond the… | Neither leg of the condition opposite is met at this date | Mozaic 4 qualification at the remaining CSPs slips beyond the September-2026 quarter. |
Dates marked as estimated are drawn from the company’s own reporting cadence, not from an announcement.
Named cause: a hyperscaler-funded second source, or CY2028 LTA renewal at flat-to-down $/TB. Mechanics: nearline capacity is allocated through CY2027 and BTO pricing is fixed through FY2027. The exposure is the CY2028 renewal. If hyperscalers respond to 50% supplier gross margins by pre-funding capacity (the pattern already visible in NAND wafer prepayments) or by holding $/TB flat at renewal, Seagate's revenue growth reverts to exabyte growth alone (mid-20s%) with gross margin compressing toward the mid-30s as areal-density gains are again passed through. Quantified: FY2028 revenue $19.0bn (m
Falsifiable and fundamental — not one of them is a price condition.
On approach to the $860.00 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Not determined | Can the intended position be built and exited in the right vehicle? Not established on the evidence on file. |
| Downside | Met | Named cause: a hyperscaler-funded second source, or CY2028 LTA renewal at flat-to-down $/TB. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Met | Is there a dated event that resolves the disagreement? |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -0.7 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is whether a position could be built and exited at the intended size. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $573.15, which forces an immediate review.